PL2772484T3 - Bicyclic heterocyclic compound - Google Patents
Bicyclic heterocyclic compoundInfo
- Publication number
- PL2772484T3 PL2772484T3 PL12840990T PL12840990T PL2772484T3 PL 2772484 T3 PL2772484 T3 PL 2772484T3 PL 12840990 T PL12840990 T PL 12840990T PL 12840990 T PL12840990 T PL 12840990T PL 2772484 T3 PL2772484 T3 PL 2772484T3
- Authority
- PL
- Poland
- Prior art keywords
- heterocyclic compound
- bicyclic heterocyclic
- bicyclic
- compound
- heterocyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/28—Cinnolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/80—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011228822 | 2011-10-18 | ||
| EP12840990.1A EP2772484B1 (en) | 2011-10-18 | 2012-10-17 | Bicyclic heterocyclic compound |
| PCT/JP2012/076771 WO2013058258A1 (en) | 2011-10-18 | 2012-10-17 | Bicyclic heterocyclic compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2772484T3 true PL2772484T3 (en) | 2017-10-31 |
Family
ID=48140904
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL12840990T PL2772484T3 (en) | 2011-10-18 | 2012-10-17 | Bicyclic heterocyclic compound |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US9266840B2 (en) |
| EP (1) | EP2772484B1 (en) |
| JP (1) | JP6020459B2 (en) |
| KR (1) | KR101987514B1 (en) |
| CN (1) | CN103917524B (en) |
| AR (1) | AR088378A1 (en) |
| AU (1) | AU2012327076B2 (en) |
| BR (1) | BR112014009524A2 (en) |
| CA (1) | CA2851589C (en) |
| CY (1) | CY1119181T1 (en) |
| DK (1) | DK2772484T3 (en) |
| EA (1) | EA024846B1 (en) |
| ES (1) | ES2641258T3 (en) |
| HR (1) | HRP20171125T1 (en) |
| IL (1) | IL232061A (en) |
| IN (1) | IN2014CN02949A (en) |
| LT (1) | LT2772484T (en) |
| ME (1) | ME02733B (en) |
| MX (1) | MX344014B (en) |
| PL (1) | PL2772484T3 (en) |
| PT (1) | PT2772484T (en) |
| RS (1) | RS56288B1 (en) |
| SI (1) | SI2772484T1 (en) |
| TW (1) | TWI545113B (en) |
| UA (1) | UA112327C2 (en) |
| WO (1) | WO2013058258A1 (en) |
| ZA (1) | ZA201403513B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013166013A1 (en) | 2012-04-30 | 2013-11-07 | Anderson Gaweco | Ror modulators and their uses |
| US9045477B2 (en) | 2013-03-15 | 2015-06-02 | Epizyme, Inc. | Substituted 6,5-fused bicyclic heteroaryl compounds |
| US9776996B2 (en) * | 2013-03-15 | 2017-10-03 | Epizyme, Inc. | Substituted 6,5-fused bicyclic heteroaryl compounds |
| CN107922386B (en) * | 2015-06-22 | 2021-04-02 | 大日本住友制药株式会社 | 1, 4-disubstituted imidazole derivatives |
| CN108129430A (en) * | 2016-11-30 | 2018-06-08 | 重庆圣华曦药业股份有限公司 | A kind of synthetic method of Li Tasite intermediates |
| CN115925692A (en) * | 2022-11-28 | 2023-04-07 | 浙江理工大学 | Preparation method of trifluoromethyl substituted enamine compound |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3770726D1 (en) * | 1986-08-12 | 1991-07-18 | Roussel Uclaf | DECAHYDROCHINOLIN DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND INTERMEDIATE PRODUCTS THEREOF, THEIR USE AS MEDICINAL PRODUCTS AND THEIR PHARMACEUTICAL COMPOSITIONS. |
| GB8907865D0 (en) * | 1989-04-07 | 1989-05-24 | Wyeth John & Brother Ltd | Tetrahydroquinoline derivatives |
| US5194439A (en) * | 1990-04-06 | 1993-03-16 | John Wyeth & Brother Limited | N-(2,3-dihydro-1,4-benzodioxinyl)-N-substituted aminopyrido-fused cycloalkanes |
| EP0787721B1 (en) | 1995-07-20 | 1999-04-28 | Toray Industries, Inc. | 4a-ARYLDECAHYDROISOQUINOLINE COMPOUNDS AND MEDICINAL USES THEREOF |
| JP2003527395A (en) | 2000-03-17 | 2003-09-16 | ノボ ノルディスク アクティーゼルスカブ | Fused imidazoles as histamine H3 receptor ligands |
| CA2479928A1 (en) | 2002-03-28 | 2003-10-09 | Neurogen Corporation | Substituted biaryl amides as c5a receptor modulators |
| EP1615698B1 (en) | 2003-04-11 | 2010-09-29 | High Point Pharmaceuticals, LLC | New amide derivatives and pharmaceutical use thereof |
| EP1675844A1 (en) * | 2003-10-23 | 2006-07-05 | Sterix Limited | Phenyl carboxamide and sulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase |
| US7842810B2 (en) | 2005-03-31 | 2010-11-30 | Janssen Pharmaceutica, Nv | Bicyclic pyrazole compounds as antibacterial agents |
| EP1864971A4 (en) * | 2005-03-31 | 2010-02-10 | Takeda Pharmaceutical | Prophylactic/therapeutic agent for diabetes |
| WO2007050124A1 (en) | 2005-05-19 | 2007-05-03 | Xenon Pharmaceuticals Inc. | Fused piperidine derivatives and their uses as therapeutic agents |
| US8952176B2 (en) | 2005-06-07 | 2015-02-10 | Shionogi & Co., Ltd. | Heterocyclic compound having type I 11 β hydroxysteroid dehydrogenase inhibitory activity |
| US7605289B2 (en) | 2005-06-17 | 2009-10-20 | Amgen, Inc. | Benzamide derivatives and uses related thereto |
| US20090163549A1 (en) | 2005-12-15 | 2009-06-25 | Hiroyuki Kai | Pharmaceutical Composition Comprising an Amide Derivative |
| EA014717B1 (en) * | 2006-04-21 | 2011-02-28 | Эли Лилли Энд Компани | Cyclohexylimidazole lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| MY148128A (en) * | 2006-04-21 | 2013-02-28 | Lilly Co Eli | Cyclohexylpyrazole-lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| DK2021337T3 (en) | 2006-04-25 | 2010-03-29 | Lilly Co Eli | Inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| US7659287B2 (en) | 2006-06-08 | 2010-02-09 | Amgen Inc. | Benzamide derivatives and uses related thereto |
| TW200808695A (en) | 2006-06-08 | 2008-02-16 | Amgen Inc | Benzamide derivatives and uses related thereto |
| WO2008065500A2 (en) * | 2006-11-30 | 2008-06-05 | Pfizer Products Inc. | Heteroaryl amides as type i glycine transport inhibitors |
| WO2008088540A2 (en) | 2006-12-26 | 2008-07-24 | Amgen Inc. | N-cyclohexyl benzamides and benzeneacetamides as inhibitors of 11-beta-hydroxysteroid dehydrogenases |
| EP2937345B1 (en) | 2009-12-29 | 2018-03-21 | Dana-Farber Cancer Institute, Inc. | Type ii raf kinase inhibitors |
| UA112418C2 (en) | 2010-09-07 | 2016-09-12 | Астеллас Фарма Інк. | THERAPEUTIC DISEASE |
| US20140031547A1 (en) | 2010-12-14 | 2014-01-30 | Electrophoretics Limited | CASEIN KINASE 1delta (CK 1delta) INHIBITORS AND THEIR USE IN THE TREATMENT OF NEURODE-GENERATIVE DISEASES SUCH AS TAUOPATHIES |
-
2012
- 2012-10-17 RS RS20170733A patent/RS56288B1/en unknown
- 2012-10-17 JP JP2013539653A patent/JP6020459B2/en active Active
- 2012-10-17 PL PL12840990T patent/PL2772484T3/en unknown
- 2012-10-17 WO PCT/JP2012/076771 patent/WO2013058258A1/en active Application Filing
- 2012-10-17 PT PT128409901T patent/PT2772484T/en unknown
- 2012-10-17 KR KR1020147012520A patent/KR101987514B1/en active IP Right Grant
- 2012-10-17 LT LTEP12840990.1T patent/LT2772484T/en unknown
- 2012-10-17 EP EP12840990.1A patent/EP2772484B1/en active Active
- 2012-10-17 MX MX2014004701A patent/MX344014B/en active IP Right Grant
- 2012-10-17 SI SI201231017T patent/SI2772484T1/en unknown
- 2012-10-17 DK DK12840990.1T patent/DK2772484T3/en active
- 2012-10-17 US US14/351,965 patent/US9266840B2/en active Active
- 2012-10-17 BR BR112014009524A patent/BR112014009524A2/en not_active Application Discontinuation
- 2012-10-17 IN IN2949CHN2014 patent/IN2014CN02949A/en unknown
- 2012-10-17 CA CA2851589A patent/CA2851589C/en active Active
- 2012-10-17 ES ES12840990.1T patent/ES2641258T3/en active Active
- 2012-10-17 UA UAA201405224A patent/UA112327C2/en unknown
- 2012-10-17 ME MEP-2017-145A patent/ME02733B/en unknown
- 2012-10-17 TW TW101138258A patent/TWI545113B/en active
- 2012-10-17 AU AU2012327076A patent/AU2012327076B2/en active Active
- 2012-10-17 CN CN201280051414.6A patent/CN103917524B/en active Active
- 2012-10-17 EA EA201490811A patent/EA024846B1/en not_active IP Right Cessation
- 2012-10-18 AR ARP120103883A patent/AR088378A1/en active IP Right Grant
-
2014
- 2014-04-10 IL IL232061A patent/IL232061A/en active IP Right Grant
- 2014-05-15 ZA ZA2014/03513A patent/ZA201403513B/en unknown
-
2017
- 2017-07-21 HR HRP20171125TT patent/HRP20171125T1/en unknown
- 2017-07-31 CY CY20171100826T patent/CY1119181T1/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2738170A4 (en) | Heterocyclic compound | |
| IL232570B (en) | Bicyclic dihydroisoquinoline-1-one derivatives | |
| HK1210769A1 (en) | Heterocyclic compound | |
| EP2889291A4 (en) | Heterocyclic compound | |
| PT2716642T (en) | Imidazopyridine compound | |
| ZA201401577B (en) | New bicyclic dihydroquinoline-2-one derivatives | |
| EP2873669A4 (en) | Heterocyclic compound | |
| EP2832734A4 (en) | Heterocyclic compound | |
| EP2709609A4 (en) | Heterocyclic compounds | |
| EP2818473A4 (en) | Heterocyclic compound | |
| EP2927229A4 (en) | Heterocyclic compound | |
| EP2772485A4 (en) | Bicyclic compound | |
| EP2840076A4 (en) | Bicyclic compound | |
| EP2857400A4 (en) | Heterocyclic compound | |
| EP2794569A4 (en) | Heterocyclic urea compounds | |
| ZA201403513B (en) | Bicyclic heterocyclic compound | |
| EP2735567A4 (en) | Heterocyclic substituted pyrimidine compound | |
| GB201121042D0 (en) | Beta-lactam compounds |